Redeye retains its highly positive stance on Genovis although we still caution that 1H'20 is likely to be adversely affected by the corona crisis. In the company's 2019 Annual Report, issued today, however, Genovis only briefly comments that it is too early to tell what the potential impact might be. As a reference, Thermo Fisher, a leading global instrument producer, recently warned about seeing a slowdown towards the end of Q1.